A combination of two drugs can selectively block pain-sensing neurons in rats without impairing movement or other sensations such as touch, according to a new study by National Institutes of Health (NIH)-supported investigators. The finding suggests an improved way to treat pain from childbirth and surgical procedures. It may also lead to new treatments to help the millions of Americans who suffer from chronic pain.

Imagine an epidural or a shot of Novocain that doesn’t paralyze your legs or make you numb, yet totally blocks your pain. This type of pain management is now within reach.

Static magnets are widely marketed to the public with claims of effectiveness for relieving pain. One survey suggests that about 28 percent of patients with rheumatoid arthritis, osteoarthritis or fibromyalgia, use magnets or copper bracelets for pain relief.

Inflammation of a tendon triggered by calcium deposits, or calcific tendinitis, can effectively be treated with a simple and cost effective percutaneous method according to a recent study conducted by researchers from the Hospital de Basurto in Bilbao, Spain.

The most commonly used measure for pain screening may only be modestly accurate, according to researchers from the Indiana University School of Medicine and the University of North Carolina.

Advances in pain and palliative care for adults have been significant in the past decade due in part to increased recognition, support and use by caregivers and patients.

People who fear aggravating a backache will change the way they move to prevent more pain, a new study finds. But doing so may set the stage for further injury, researchers warn.

The intensive training given to young elite tennis players damages their spines, shows research published ahead of print in the British Journal of Sports Medicine.

Anybody who’s tried to concentrate on work while suffering a headache knows that pain compellingly commands attention—which is how evolution helped ensure survival in a painful world. Now, researchers have pinpointed the brain region responsible for pain’s ability to affect cognitive processing.

The U.S. Food and Drug Administration approved on June 21st Lyrica (pregabalin), the first drug fibromyalgia treatment, a disorder characterized by pain, fatigue and sleep problems.